Dr. Werner Lanthaler is Vice Chairman at argenx SE, Chief Executive Officer at Evotec AG and Chairman-Supervisory Board at Topas Therapeutics GmbH.
He is on the Board of Directors at argenx SE. Dr. Lanthaler was previously employed as Chief Financial Officer by Intercell AG and Member-Supervisory Board by DeveloGen AG.
He also served on the board at Federation of Austrian Industry, BioXell SpA and Pantec Biosolutions AG.
He received his graduate degree from Harvard University and a doctorate degree from the University of Vienna.